NCT05884476 Randomized Clinical Trial of Re-Evaluating Suicidal Thoughts in Veterans
| NCT ID | NCT05884476 |
| Status | Recruiting |
| Phase | — |
| Sponsor | VA Office of Research and Development |
| Condition | Suicidal Ideation |
| Study Type | INTERVENTIONAL |
| Enrollment | 180 participants |
| Start Date | 2024-01-08 |
| Primary Completion | 2027-06-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 180 participants in total. It began in 2024-01-08 with a primary completion date of 2027-06-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Suicide prevention is a top priority for VA as all continue to seek new and inventive ways to reduce suicide rates among Veterans. Many experts agree that suicide prevention efforts could be improved by making suicide-specific interventions easier to access. The current project aims to move toward that goal by testing a web-based suicide prevention intervention using an experimental design. The roughly 40-minute intervention aims to teach Veterans coping skills that are designed to ease the emotional distress that often comes with thoughts of suicide. The project will evaluate whether Veterans who receive this intervention report more improvement in suicidal thoughts and behaviors than Veterans who receive a standard course of health care visits. Suicidal thoughts and behaviors will be measured over the course of one month. The investigators hypothesize that Veterans who receive the intervention will report lower suicidal thoughts and behaviors than those who receive the standard course of health care.
Eligibility Criteria
Inclusion Criteria: * Veteran * 18 years or older * Past two-week suicidal ideation as indicated by positive reply to C-SSRS questions ("Have you had any actual thoughts of killing yourself," or, "Have you been thinking about how you might do this?") Exclusion Criteria: * Active psychosis * Unmedicated bipolar disorder * Instances in which a substance use disorder would indicate inpatient detoxification prior to engaging in other outpatient mental health interventions
Contact & Investigator
Joseph W Boffa, PhD
PRINCIPAL INVESTIGATOR
Southeast Louisiana Veterans Health Care System, New Orleans, LA
Frequently Asked Questions
Who can join the NCT05884476 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Suicidal Ideation. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05884476 currently recruiting?
Yes, NCT05884476 is actively recruiting participants. Contact the research team at joseph.boffa@va.gov for enrollment information.
Where is the NCT05884476 trial being conducted?
This trial is being conducted at New Orleans, United States.
Who is sponsoring the NCT05884476 clinical trial?
NCT05884476 is sponsored by VA Office of Research and Development. The principal investigator is Joseph W Boffa, PhD at Southeast Louisiana Veterans Health Care System, New Orleans, LA. The trial plans to enroll 180 participants.